GSK ( LON:GSK – Get Rating ) has been given a GBX 1,400 ($17.19) target price by stock analysts at JPMorgan Chase & Co. in a report released on Friday, Borsen Zeitung reports. JPMorgan Chase & Co. ‘s price target would indicate a potential upside of 0.03% from the company's previous close. Other equities analysts have also issued reports about the company. Citigroup dropped their price objective on GSK from GBX 1,975 ($24.25) to GBX 1,550 ($19.03) and set a 'neutral' rating on the stock in a research note on Friday, December 2nd.

https://www.dailypolitical.com/2023/03/24/jpmorgan-chase-co-reiterates-gbx-1400-price-target-for-gsk-longsk.html

#dailypolitical